Business meeting to consider S.331, to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and the nomination of Kashyap Patel, of Nevada, to be Director of the Federal Bureau of Investigation, Department of Justice. | ChamberLight
Business meeting to consider S.331, to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and the nomination of Kashyap Patel, of Nevada, to be Director of the Federal Bureau of Investigation, Department of Justice.
Thursday, February 13, 2025 at 2:00 PMDirksen Senate Office Building, Room 216